Skip to main content

Advertisement

Log in

Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The purpose of this study was to examine cognitive function in patients with early breast cancer before and after adjuvant chemotherapy or 6 months of tamoxifen. We performed a population-based study in the county of North Jutland, Denmark, including 120 women aged <60 years who received adjuvant chemotherapy with seven cycles of cyclophosphamide, epirubicin and fluoruracil or adjuvant tamoxifen for 6 months for early breast cancer from 2004 to 2006. They were compared with an aged-matched group of 208 women without previous cancer selected randomly from the same population. Data were collected before start of adjuvant treatment and after 6 months by neuropsychological tests and questionnaires to evaluate cognitive function, quality of life and psychological distress. Neuropsychological tests did not reveal any differences in cognitive function between breast cancer patients after chemotherapy and healthy controls. Patients rated their own cognitive functions as improved after 6 months, and patients, who did not receive adjuvant medical treatment, reached the same level as controls within 6 months. Patients receiving chemotherapy or tamoxifen were up to three times more likely than controls to rate themselves as impaired at 6 months. Our results do not support that adjuvant chemotherapy is associated with cognitive side effects in breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

    Article  CAS  Google Scholar 

  2. Nelson CJ, Nandy N, Roth AJ (2007) Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care 5:273–280

    PubMed  Google Scholar 

  3. Schagen SB, van Dam FS, Muller MJ et al (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–650

    Article  CAS  PubMed  Google Scholar 

  4. Wieneke MH, Dienst E (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 4:61–66

    Article  Google Scholar 

  5. Schagen SB, Muller MJ, Boogerd W et al (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98:1742–1745

    Article  PubMed  CAS  Google Scholar 

  6. Jenkins V, Shilling V, Deutsch G et al (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828–834

    Article  CAS  PubMed  Google Scholar 

  7. Falleti MG, Sanfilippo A, Maruff P et al (2005) The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 59:60–70

    Article  PubMed  Google Scholar 

  8. Shilling V, Jenkins V, Trapala IS (2006) The (mis)classification of chemo-fog—methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 95:125–129

    Article  PubMed  Google Scholar 

  9. Paganini-Hill A, Clark LJ (2000) Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64:165–176

    Article  CAS  PubMed  Google Scholar 

  10. Jenkins V, Shilling V, Fallowfield L et al (2004) Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 13:61–66

    Article  PubMed  Google Scholar 

  11. Palmer JL, Trotter T, Joy AA et al (2008) Cognitive effects of tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. J Cancer Surviv Res Pract 2:275–282

    Article  Google Scholar 

  12. Debess J, Riis JØ, Pedersen L et al (2008) Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark. Acta Oncol 48:532–540

    Article  Google Scholar 

  13. ISPOC (2006) International study on postoperative cognitive dysfunction. www.sps.ele.tue.nl/ispocd/index.html

  14. Schwarzer R, Jerusalem M (1995) Measures in health psychology: a user’s portfolio. Causal Control Beliefs 1:35–37

    Google Scholar 

  15. Luszczynska A, Gutiérrez-Doña B, Schwarzer R (2005) General self-efficacy in various domains of human functioning: evidence from five countries. Int J Psychol 40:80–89

    Article  Google Scholar 

  16. McNair DM, Heuchert JW (2003) Profile of mood states technical updates. Multi-Health Systems Inc, New York

    Google Scholar 

  17. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  CAS  PubMed  Google Scholar 

  18. Fayers PM, Aaronson NK, Bjordal K et al (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels

    Google Scholar 

  19. Fayers P, Bottomley A (2002) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Eur J Cancer 38(Suppl 4):S125–S133

    Article  PubMed  Google Scholar 

  20. Castaneda AE, Tuulio-Henriksson A, Marttunen M et al (2008) A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 106:1–27

    Article  PubMed  Google Scholar 

  21. Temkin NR, Heaton RK, Grant I et al (1999) Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc 5:357–369

    Article  CAS  PubMed  Google Scholar 

  22. Resnick SM, Maki PM, Rapp SR et al (2006) Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 91:1802–1810

    Article  CAS  PubMed  Google Scholar 

  23. Hermelink K, Untch M, Lux MP et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905–1913

    Article  CAS  PubMed  Google Scholar 

  24. Mehlsen M, Pedersen AD, Jensen AB et al (2009) No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology 18:248–257

    Article  PubMed  Google Scholar 

  25. Wefel JS, Lenzi R, Theriault RL et al (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292–2299

    Article  CAS  PubMed  Google Scholar 

  26. Bender CM, Sereika SM, Berga SL et al (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422–430

    Article  PubMed  Google Scholar 

  27. Hurria A, Rosen C, Hudis C et al (2006) Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54:925–931

    Article  PubMed  Google Scholar 

  28. Shilling V, Jenkins V (2007) Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 11:6–15

    Article  PubMed  Google Scholar 

  29. Servaes P, Verhagen CA, Bleijenberg G (2002) Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior. Cancer 95:2017–2026

    Article  PubMed  Google Scholar 

  30. Dawson B, Trapp RG (2001) Basic & clinical biostatistics, 3rd edn. Lange Medical Books/McGraw-Hill Medical Publishing Division, New York

    Google Scholar 

  31. Collins B, Mackenzie J, Stewart A et al (2009) Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study. Psychooncology 18:811–821

    Article  PubMed  Google Scholar 

  32. Schilder CM, Eggens PC, Seynaeve C et al (2009) Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol 48:76–85

    Article  CAS  PubMed  Google Scholar 

  33. Moller JT, Cluitmans P, Rasmussen LS et al (1998) Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 351:857–861

    Article  CAS  PubMed  Google Scholar 

  34. Jansen CE, Miaskowski C, Dodd M et al (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104:2222–2233

    Article  PubMed  Google Scholar 

  35. Castellon SA, Ganz PA, Bower JE et al (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955–969

    Article  PubMed  Google Scholar 

  36. Stewart A, Collins B, Mackenzie J et al (2008) The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psychooncology 17:122–130

    Article  PubMed  Google Scholar 

  37. van Dam FS, Schagen SB, Muller MJ et al (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218

    Article  PubMed  Google Scholar 

  38. Tannock IF, Ahles TA, Ganz PA et al (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22:2233–2239

    Article  PubMed  Google Scholar 

  39. Burgess C, Cornelius V, Love S et al (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330:702. doi:10.1136/bmj.38343.670868.D3

    Article  PubMed  Google Scholar 

  40. Mehnert A, Koch U (2007) Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psychooncology 16:181–188

    Article  PubMed  Google Scholar 

  41. Christensen S, Zachariae R, Jensen AB et al (2008) Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 113:339–355

    Article  PubMed  Google Scholar 

  42. Shapiro CL, Recht A (2001) Side effects of adjuvant treatment of breast cancer. N Engl J Med 344:1997–2008

    Article  CAS  PubMed  Google Scholar 

  43. Browall M, Ahlberg K, Karlsson P et al (2008) Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women. Eur J Oncol Nurs 12:180–189

    Article  PubMed  Google Scholar 

  44. Brandberg Y, Michelson H, Nilsson B et al (2003) Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401. J Clin Oncol 21:3659–3664

    Article  CAS  PubMed  Google Scholar 

  45. Schou I, Ekeberg O, Ruland CM (2005) The mediating role of appraisal and coping in the relationship between optimism-pessimism and quality of life. Psychooncology 14:718–727

    Article  CAS  PubMed  Google Scholar 

  46. Klee M, Groenvold M, Machin D (1997) Quality of life of Danish women: population-based norms of the EORTC QLQ-C30. Qual Life Res 6:27–34

    Article  CAS  PubMed  Google Scholar 

  47. Ouimet LA, Stewart A, Collins B et al (2008) Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models. J Clin Exp Neuropsychol 31(1):73–89

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by the Danish Cancer Society.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marianne Ewertz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Debess, J., Riis, J.Ø., Engebjerg, M.C. et al. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat 121, 91–100 (2010). https://doi.org/10.1007/s10549-010-0756-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0756-8

Keywords

Navigation